Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults

Completed · Not applicable

Conditions studied: Hepatitis c

In brief

The purpose of the LEAP-C (learning, experiencing and preparing for hepatitis C treatment) study is to see if a brief (4-week) small group intervention will help people with HIV/HCV co-infection make an informed decision about Hepatitis C treatment.

Key facts

Study ID

NCT01472354

Run by

University of Massachusetts, Worcester

People needed

50

Starts

2010-10-01

Expected to finish

2012-11-01

Last updated by the study team

2013-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and Women (18 years of age or older) who have both HIV and chronic Hepatitis C (they need to have a detectable Hepatitis C viral load)
• HIV/HCV co-infected adults who have NEVER started treatment
• HIV/HCV co-infected adults who DO NOT have a MEDICAL reason that would make it dangerous to treat their hepatitis C (for example, severe cirrhosis already)
• HIV/HCV co-infected adults who would be willing to be RANDOMIZED into a group session or standard of care (one on one care with a HCV provider)

You may not qualify if…

• Non-English Speaking
• Children under age 18
• HCV mono-infected adults
• HIV/HCV co-infected adults who have received any HCV treatment

Where it is running

• University of Massachusetts Graduate School of Nursing — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.